Immunitas Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 21, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $39,000,000
Company Info
- Founders
- Lea Hachigian, Ph.D.
- Company Description
- Immunitas Therapeutics employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the bench into meaningful clinical improvements. Our focus on human data allows us to start with and stay closer to the biology that is most relevant in patients and greatly accelerates the pace of our research.
- Market
- Cancer therapeutics
- Location
- Cambridge, MA, USA
- Coinvestors
- Alexandria Venture Investments, Evotec, Leaps by Bayer, M Ventures, Novartis Venture Fund